Amarantus BioScience Holdings, Inc.
AMBS · OTC
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $0 | $0 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $0 | $0 | $0 | $0 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $10 | $10 | $12 | $11 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $10 | $10 | $12 | $11 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $10 | $10 | $12 | $11 |
| Liabilities | – | – | – | – |
| Payables | $15 | $15 | $15 | $15 |
| Short-Term Debt | $19 | $19 | $19 | $19 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $0 | $0 |
| Total Curr. Liab. | $35 | $35 | $35 | $35 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $35 | $35 | $35 | $35 |
| Equity | – | – | – | – |
| Pref Stock | $2 | $2 | $2 | $2 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$107 | -$106 | -$105 | -$105 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $80 | $80 | $80 | $80 |
| Total Equity | -$25 | -$25 | -$23 | -$24 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $10 | $10 | $12 | $11 |
| Net Debt | $19 | $19 | $19 | $19 |